Callan Family Office LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Callan Family Office LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 822.9% in the 4th quarter, HoldingsChannel reports. The firm owned 31,361 shares of the healthcare conglomerate’s stock after purchasing an additional 27,963 shares during the period. UnitedHealth Group makes up about 1.0% of Callan Family Office LLC’s holdings, making the stock its 18th largest holding. Callan Family Office LLC’s holdings in UnitedHealth Group were worth $15,864,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Chatham Capital Group Inc. raised its holdings in UnitedHealth Group by 0.5% in the 4th quarter. Chatham Capital Group Inc. now owns 11,262 shares of the healthcare conglomerate’s stock valued at $5,697,000 after acquiring an additional 60 shares during the last quarter. Welch & Forbes LLC lifted its position in UnitedHealth Group by 5.6% during the fourth quarter. Welch & Forbes LLC now owns 5,322 shares of the healthcare conglomerate’s stock worth $2,692,000 after buying an additional 284 shares during the period. E Fund Management Co. Ltd. increased its stake in shares of UnitedHealth Group by 56.6% during the 4th quarter. E Fund Management Co. Ltd. now owns 10,634 shares of the healthcare conglomerate’s stock valued at $5,379,000 after acquiring an additional 3,843 shares during the last quarter. Chung Wu Investment Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $3,274,000. Finally, Vestmark Advisory Solutions Inc. increased its position in UnitedHealth Group by 32.0% during the fourth quarter. Vestmark Advisory Solutions Inc. now owns 7,284 shares of the healthcare conglomerate’s stock worth $3,685,000 after purchasing an additional 1,764 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $487.76 on Friday. The company’s 50-day simple moving average is $514.11 and its 200-day simple moving average is $554.35. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $448.87 billion, a price-to-earnings ratio of 31.47, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Truist Financial dropped their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.